Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Harvard Business School
Argus Health

Generated: June 24, 2017

DrugPatentWatch Database Preview

Diatrizoate meglumine; diatrizoate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diatrizoate meglumine; diatrizoate sodium and what is the scope of diatrizoate meglumine; diatrizoate sodium freedom to operate?

Diatrizoate meglumine; diatrizoate sodium
is the generic ingredient in seventeen branded drugs marketed by Ge Healthcare, Bayer Hlthcare, Bracco, Intl Medication, Mallinckrodt, and Liebel-flarsheim, and is included in thirteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate meglumine; diatrizoate sodium. Two suppliers are listed for this compound.

Summary for Generic Name: diatrizoate meglumine; diatrizoate sodium

Drug Master File Entries: see list9
Suppliers / Packagers: see list2
Clinical Trials: see list2,372
Drug Prices:see low prices
DailyMed Link:diatrizoate meglumine; diatrizoate sodium at DailyMed

Pharmacology for Ingredient: diatrizoate meglumine; diatrizoate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION010040-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
diatrizoate meglumine; diatrizoate sodium
SOLUTION;ORAL, RECTAL011245-003Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe
diatrizoate meglumine; diatrizoate sodium
SOLUTION;ORAL, RECTAL087388-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe
Intl Medication
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION088166-001Jun 17, 1983DISCNNoNo► Subscribe► Subscribe
diatrizoate meglumine; diatrizoate sodium
INJECTABLE;INJECTION087074-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Fish and Richardson
Argus Health
Johnson and Johnson
Queensland Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus